T2 Biosystems

T2 Biosystems Says Panel Can Detect Covid Variants, Shares Up 26%

Shares of T2 Biosystems, Inc. are trading over 26% higher after hours Thursday following the company's announcement that its T2SARS-CoV-2 Panel is capable of detecting the Mu and Iota variants of SARS-CoV-2 virus.

The company said the T2SARS-CoV-2 Panel is a "molecular diagnostic test that detects SARS-CoV-2, the virus responsible for Covid-19 infections."

At 5:29 p.m. EDT, the company's shares were trading 26.93% higher at $1.10 a share. Volume at the time topped 2.3 million shares.


...

https://www.marketwatch.com/story/t2-bio...quote_news

T2 Biosystems Announces Distribution Agreements in Key Asia-Pacific Markets

Expands International Commercialization with Initial Shipment of T2Dx Instruments to Asia

LEXINGTON, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of territory exclusive distribution agreements in Singapore and South Korea. Under the terms of the agreements, T2 Biosystems will sell T2Dx® Instruments, along with T2Bacteria®, T2Candida® and T2Resistance® Panels through these distributors.


...

https://finance.yahoo.com/news/t2-biosys...00277.html

TTOO nachbörslich +18%